We are live on
!
Find out more
WP
WMS Partners Portfolio holdings
AUM
$1.78B
1-Year Est. Return
11.82%
This Fund
S&P 500
This Quarter
Est. Return
+5.57%
1 Year Est. Return
+11.82%
3 Year Est. Return
+10.77%
5 Year Est. Return
+74.56%
10 Year Est. Return
+198.1%
AUM
$1.78B
AUM Growth
+$219M
(+14%)
Cap. Flow
+$134M
Cap. Flow
% of AUM
7.5%
Top 10 Holdings %
Top 10 Hldgs %
52.57%
Holding
320
New
56
Increased
123
Reduced
89
Closed
21
Top Buys
| 1 |
JPMorgan Core Plus Bond ETF
JCPB
|
+$12.3M |
| 2 |
Microsoft
MSFT
|
+$10.1M |
| 3 |
Apple
AAPL
|
+$9.78M |
| 4 |
Avantis US Mid Cap Equity ETF
AVMC
|
+$9.73M |
| 5 |
Avantis International Equity ETF
AVDE
|
+$7.54M |
Top Sells
| 1 |
iShares Core S&P Small-Cap ETF
IJR
|
+$5.83M |
| 2 |
Axsome Therapeutics
AXSM
|
+$3.28M |
| 3 |
Danaher
DHR
|
+$2.11M |
| 4 |
O'Reilly Automotive
ORLY
|
+$1.43M |
| 5 |
Align Technology
ALGN
|
+$1.21M |
Sector Composition
| 1 | Financials | 9.63% |
| 2 | Technology | 7.05% |
| 3 | Healthcare | 2.2% |
| 4 | Consumer Staples | 1.98% |
| 5 | Communication Services | 1.81% |
Similar funds
RDIA
CFGS
KL
ZB
GA
LSAG
IFLIT
ECG
WMS Partners's Q3 2024 Portfolio in Review
As of Q3 2024, WMS Partners held 320 positions worth $1.78B, up 14% from $1.56B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
WMS Partners deployed $134M of net new capital in Q3 2024, opening 56 new positions and adding to 123 existing holdings. Its largest new stake was Avantis US Mid Cap Equity ETF: 159,046 shares worth $10.2M.
By sector, the portfolio is most concentrated in Financials at 9.6% of assets, down from 9.9% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares Core S&P Small-Cap ETF, an estimated $5.83M trimmed.
- WMS Partners's largest Q3 2024 buy was Avantis US Mid Cap Equity ETF: 159,046 shares worth $10.2M.
- WMS Partners added most to JPMorgan Core Plus Bond ETF in Q3 2024, an estimated $12.3M increase.
- WMS Partners's biggest Q3 2024 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $5.83M.
- WMS Partners fully exited Axsome Therapeutics in Q3 2024, selling an estimated $3.28M.
- WMS Partners's ten largest holdings make up 53% of its $1.78B portfolio in Q3 2024.
- WMS Partners opened 56 new positions and closed 21 in Q3 2024.
- WMS Partners's portfolio value rose 14% quarter-over-quarter to $1.78B.
Based on WMS Partners's 13F filing for Q3 2024, filed 13 Nov 2024.